Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Arax Capital Partners

Founders Christian Tiringer Daniel Cesky

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 42
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 16
Rounds per year 2.47
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.62
Exits 4
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Information Technology
  • Manufacturing
Summary

Arax Capital Partners appeared to be the VC, which was created in 2007. The main department of described VC is located in the Vienna. The venture was found in Europe in Austria.

The fund was created by Christian Tiringer, Daniel Cesky. The overall number of key employees were 1.

Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2015. When the investment is from Arax Capital Partners the average startup value is 10-50 millions dollars. The top activity for fund was in 2013. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. Opposing the other organizations, this Arax Capital Partners works on 24 percentage points less the average amount of lead investments. The real fund results show that this VC is 15 percentage points less often commits exit comparing to other companies.

For fund there is a match between the location of its establishment and the land of its numerous investments - Austria. Among the most successful fund investment fields, there are Information Technology, Semiconductor. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Nabriva Therapeutics, AFFiRiS, EUCODIS Bioscience. The fund has exact preference in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Arax Capital Partners, startups are often financed by MIG AG, bmp Ventures, RFID Invest. The meaningful sponsors for the fund in investment in the same round are MIG AG, aws Gru00fcnderfonds (aws Founders Fund), Wiener Wachstumsfonds. In the next rounds fund is usually obtained by MIG AG, bmp Ventures, aws Mittelstandsfonds.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Arax Capital Partners:
Typical Co-investors
Arax Capital Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Arax Capital Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Austria
Funds with similar focus located in Austria:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Greenpass

Architecture
CleanTech
SaaS
24 Sep 2024 -

Calyxha Biotechnologies GmbH

$1M28 Feb 2020 -

EveliQure Biotechnologies GmbH

Life Science
$2M01 Jul 2019 Vienna, Austria

The MoonVision

Artificial Intelligence
Information Services
Information Technology
Software
$708K31 Jan 2019 Vienna, Austria

Panoptes Pharma

Biotechnology
02 Nov 2015 Vienna, Austria

crystalsol

Renewable Energy
Semiconductor
Solar
Sustainability
$9M30 Jan 2013 Austria, Vienna

Marinomed

Biopharma
Biotechnology
Health Care
Medical
Product Design
Therapeutics
$182K30 Jun 2012 Austria, Vienna

crystalsol

Renewable Energy
Semiconductor
Solar
Sustainability
$944K31 Dec 2011 Vienna, Austria

EUCODIS Bioscience

Biopharma
Biotechnology
Cosmetics
Medical
Medical Device
$2M17 Mar 2010 Austria, Vienna

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Arax Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 42
Average round size 1M
Rounds per year 2.47
Peak activity year 2013
Lead investments 2
Follow on index 0.62
Exits 4
Group Appearance index 0.14

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Greenpass

Architecture
CleanTech
SaaS
24 Sep 2024 -

Calyxha Biotechnologies GmbH

$1M28 Feb 2020 -

EveliQure Biotechnologies GmbH

Life Science
$2M01 Jul 2019 Vienna, Austria

The MoonVision

Artificial Intelligence
Information Services
Information Technology
Software
$708K31 Jan 2019 Vienna, Austria

Panoptes Pharma

Biotechnology
02 Nov 2015 Vienna, Austria

crystalsol

Renewable Energy
Semiconductor
Solar
Sustainability
$9M30 Jan 2013 Austria, Vienna

Marinomed

Biopharma
Biotechnology
Health Care
Medical
Product Design
Therapeutics
$182K30 Jun 2012 Austria, Vienna

crystalsol

Renewable Energy
Semiconductor
Solar
Sustainability
$944K31 Dec 2011 Vienna, Austria

EUCODIS Bioscience

Biopharma
Biotechnology
Cosmetics
Medical
Medical Device
$2M17 Mar 2010 Austria, Vienna
Crunchbase icon

Content report

The following text will be sent to our editors: